GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain

被引：51

作者：

Bamborough, Paul ^{[4
]}

Barnett, Heather A. ^{[3
]}

Becher, Isabelle ^{[5
,8
]}

Bird, Mark J. ^{[3
]}

Chung, Chun-wa ^{[4
]}

Craggs, Peter D. ^{[4
]}

Demont, Emmanuel H. ^{[1
]}

Diallo, Hawa ^{[1
]}

Fallon, David J. ^{[1
,6
]}

Gordon, Laurie J. ^{[4
]}

Grandi, Paola ^{[5
]}

Hobbs, Clare I. ^{[4
]}

Hooper-Greenhill, Edward ^{[2
]}

Jones, Emma J. ^{[4
]}

Law, Robert P. ^{[1
,6
]}

Le Gall, Armelle ^{[4
]}

Lugo, David ^{[2
]}

Michon, Anne-Marie ^{[5
]}

Mitchell, Darren J. ^{[1
]}

Prinjha, Rab K. ^{[1
]}

Sheppard, Robert J. ^{[1
,7
]}

Watson, Allan J. B. ^{[6
]}

Watson, Robert J. ^{[1
]}

机构：

[1] GlaxoSmithKline, Epinova Discovery Performance Unit, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England

[2] GlaxoSmithKline, Quantitat Pharmacol Expt Med Unit, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline, Flexible Discovery Unit, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England

[4] GlaxoSmithKline, Platform Technol & Sci, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England

[5] GlaxoSmithKline, Cellzome GmbH, Meyerhofstr 1, D-69117 Heidelberg, Germany

[6] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Thomas Graham Bldg,295 Cathedral St, Glasgow G1 1XL, Lanark, Scotland

[7] AstraZeneca, Oncol Innovat Med & Early Dev, Cambridge Sci Pk,Milton Rd, Cambridge CB4 OWG, England

[8] European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69012 Heidelberg, Germany

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 06期

关键词：

BRPF1; BRPF2; BRD1; BRPF3; BET; bromodomain; epigenetics; chemical probe; inhibitor; HISTONE ACETYLTRANSFERASE; RECOGNITION; DISCOVERY; INSIGHTS; MOZ;

D O I：

10.1021/acsmedchemlett.6b00092

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micro molar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies.

引用

页码：552 / 557

页数：6

共 23 条

[1] Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
Bennett, James
Fedorov, Oleg
Tallant, Cynthia
Monteiro, Octovia
Meier, Julia
Gamble, Vicky
Savitsky, Pavel
Nunez-Alonso, Graciela A.
Haendler, Bernard
Rogers, Catherine
Brennan, Paul E.
Mueller, Susanne
Knapp, Stefan
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1642 - 1647
[2] The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease
Carlson, Samuel
Glass, Karen C.
[J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (11) : 1571 - 1574
[3] Chung C., 2012, DRUG DISCOV TODAY, V9, pe111, DOI DOI 10.1016/J.DDSTR.2011.12.002
[4] Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chung, Chun-wa
Coste, Herve
White, Julia H.
Mirguet, Olivier
Wilde, Jonathan
Gosmini, Romain L.
Delves, Chris
Magny, Sylvie M.
Woodward, Robert
Hughes, Stephen A.
Boursier, Eric V.
Flynn, Helen
Bouillot, Anne M.
Bamborough, Paul
Brusq, Jean-Marie G.
Gellibert, Francoise J.
Jones, Emma J.
Riou, Alizon M.
Homes, Paul
Martin, Sandrine L.
Uings, Iain J.
Toum, Jerome
Clement, Catherine A.
Boullay, Anne-Benedicte
Grimley, Rachel L.
Blande, Florence M.
Prinjha, Rab K.
Lee, Kevin
Kirilovsky, Jorge
Nicodeme, Edwige
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (11) : 3827 - 3838
[5] 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain
Demont, Emmanuel H.
Bamborough, Paul
Chung, Chun-wa
Craggs, Peter D.
Fallon, David
Gordon, Laurie J.
Grandi, Paola
Hobbs, Clare I.
Hussain, Jameed
Jones, Emma J.
Le Gall, Armelle
Michon, Anne-Marie
Mitchell, Darren J.
Prinjha, Rab K.
Roberts, Andy D.
Sheppard, Robert J.
Watson, Robert J.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (11): : 1190 - 1195
[6] TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
Deplus, Rachel
Delatte, Benjamin
Schwinn, Marie K.
Defrance, Matthieu
Mendez, Jacqui
Murphy, Nancy
Dawson, Mark A.
Volkmar, Michael
Putmans, Pascale
Calonne, Emilie
Shih, Alan H.
Levine, Ross L.
Bernard, Olivier
Mercher, Thomas
Solary, Eric
Urh, Marjeta
Daniels, Danette L.
Fuks, Francois
[J]. EMBO JOURNAL, 2013, 32 (05) : 645 - 655
[7] Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, Panagis
Knapp, Stefan
[J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (05) : 339 - 358
[8] Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, Panagis
Picaud, Sarah
Mangos, Maria
Keates, Tracy
Lambert, Jean-Philippe
Barsyte-Lovejoy, Dalia
Felletar, Ildiko
Volkmer, Rudolf
Mueller, Susanne
Pawson, Tony
Gingras, Anne-Claude
Arrowsmith, Cheryl H.
Knapp, Stefan
[J]. CELL, 2012, 149 (01) : 214 - 231
[9] Selective inhibition of BET bromodomains
Filippakopoulos, Panagis
Qi, Jun
Picaud, Sarah
Shen, Yao
Smith, William B.
Fedorov, Oleg
Morse, Elizabeth M.
Keates, Tracey
Hickman, Tyler T.
Felletar, Ildiko
Philpott, Martin
Munro, Shonagh
McKeown, Michael R.
Wang, Yuchuan
Christie, Amanda L.
West, Nathan
Cameron, Michael J.
Schwartz, Brian
Heightman, Tom D.
La Thangue, Nicholas
French, Christopher A.
Wiest, Olaf
Kung, Andrew L.
Knapp, Stefan
Bradner, James E.
[J]. NATURE, 2010, 468 (7327) : 1067 - 1073
[10] BET bromodomain inhibitors: a patent review
Garnier, Jean-Marc
Sharp, Phillip P.
Burns, Christopher J.
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (02) : 185 - 199

← 1 2 3 →